Penny stocks are incredibly dangerous investments that can burn new and seasoned investors alike. InvestorPlace’s best micro-cap analysts recommend buying penny stocks, or cheap stocks, only with the strictest of warnings. But while pink sheet stocks can be halved in the blink of an eye, they can also double much quicker than large-cap stocks.
Penny Stocks
Despite Its Best Attempts, Naked Brands Is Unlikely to Recover
Things are unlikely to change much for NAKD stock, with several loopholes in Naked Brands' turnaround strategy at this time.
The Moonshot Investor: Golden Rule Investing for Penny Stocks
Wall Street often overlooks penny stocks. Retail investors can use a winning strategy to get ahead of the curve and beat out hedge funds.
Visit Camber Energy for the Meme Chatter, Stay for the ESG Patent
CEI stock might profit from a Reddit-fueled run-up, or because of an intriguing IP agreement. Either way, the stock's worth a look.
If at First Zomedica Doesn’t Succeed, It Tries, Tries Again
The launch of the Truforma diagnostic platform didn't go perfectly for Zomedica, but holders of ZOM stock still have reason for optimism.
After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble
There's no denying that PMCB stock has lost much of its value over the years. However, recent developments could catalyze a price resurgence.
Naked Brands Is a Favorable Risk-to-Reward Trade
NAKD stock offers a good risk-to-reward trade for risk-seeking investors. The stock could soar upon a successful acquisition.
Sundial Growers Is Not Worth the Sum of All Its Parts
Add up all its investments and revenue streams and Sundial still isn’t worth $1.54 billion. Investors should pass on SNDL stock.
Sundial Growers Stock Looks as If It May Be Coming To Life Before Too Long
Past the headline weakness, there were some upbeat points in Sundial's latest earnings report. SNDL stock could be turning the corner here.
Naked Brand Could Rally Until Its Merger Plans Become Definitive
It's still not a sure thing, but some traders may want to buy NAKD stock before more details about its possible merger plans emerge.
Afghanistan Disaster Will Be a Headache for Sundial Growers
Although SNDL stock remains a “cheap” investment, it might stay that way due to political pressure affecting Washington.
Exela Stock Has All the Trappings of a Reddit Favorite
With a high short interest ratio and a tech-heavy operating model, XELA stock has all the makings of a potentially enticing Reddit favorite.
SOS Stock Is a Risky Mining Play For Leveraged Bitcoin Exposure
Chinese crypto mining play SOS stock has fallen off a cliff recently, but the stock is still good for those looking to scalp profits.
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To Impress
Atossa’s COVID-19 treatment is too little too late and I am concerned about the market size for Endoxiden. ATOS stock should not have a $448 million market cap.
Atossa Therapeutics Has a Steep Climb Ahead of It
Atossa Therapeutics is popular with the Reddit crowd. However, ATOS stock doesn’t make the top 25 on the platform. Should you buy it anyway?
